HSF1 and non-small cell lung carcinoma: Inhibiting HSF1 by small molecules enhances the effectiveness of the aurora kinase inhibitor efficacy in NSCLC by promoting apoptosis, potentially overcoming chemoresistance through PI3K/AKT pathway downregulation and ROS activation (Zhang et al., 2024).